





































































New approaches targeting brown adipose tissue transplantation as a 3 
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Brown adipose tissue (BAT) is raising high expectations as a potential target in the fight against 41 
metabolic disorders such as obesity and type 2 diabetes. BAT utilizes fuels such as fatty acids to 42 
maintain body temperature by uncoupling mitochondrial electron transport to produce heat 43 
instead of ATP. This process is called thermogenesis. BAT was considered to be exclusive to 44 
rodents and human neonates. However, in the last decade several studies have demonstrated that 45 
BAT is not only present but also active in adult humans and that its activity is reduced in several 46 
pathological conditions, such as aging, obesity, and diabetes. Thus, tremendous efforts are being 47 
made by the scientific community to enhance either BAT mass or activity. Several activators of 48 
thermogenesis have been described, such as natriuretic peptides, bone morphogenic proteins, or 49 
fibroblast growth factor 21. Furthermore, recent studies have tested a therapeutic approach to 50 
directly increase BAT mass by the implantation of either adipocytes or fat tissue. This approach 51 
might have an important future in regenerative medicine and in the fight against metabolic 52 
disorders. Here, we review the emerging field of BAT transplantation including the various 53 
sources of mesenchymal stem cell isolation in rodents and humans and the described metabolic 54 
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1. Introduction 78 
Current society embraces high calorie intake and a sedentary lifestyle, which is triggering an 79 
alarming increase in obesity and associated metabolic diseases, such as type 2 diabetes, insulin 80 
resistance, Alzheimer’s, cardiovascular diseases, and some forms of cancer. Despite the efforts 81 
made at various levels (government, education and research) to promote healthy policies, the rise 82 
in obesity is far from being stopped or decreased. 83 
In this milieu, new, successful, long-term efficient therapies need to be developed urgently. In 84 
the last decade, an attractive target has emerged in the field. This is the last tissue to be 85 
discovered in humans: brown adipose tissue (BAT). BAT utilizes fuel such as fatty acids (FAs) 86 
to control body temperature by thermogenesis. Thus, BAT dissipates energy to produce heat. 87 
Initially described as exclusive to rodents and human neonates, BAT is now commonly accepted 88 
to be present and active in adult humans [1–8]. Interestingly, women have both higher BAT 89 
mass and activity [3]. Importantly, BAT activity decreases with aging, obesity, and type 2 90 
diabetes [3]. It has been reported that in these conditions BAT shows signs of hypertrophy and a 91 
blunted response to adrenergic stimulus [6,9]. The decrease in cold-activated BAT activity in the 92 
elderly may be associated with accumulation of adiposity with age [10]. Recently, it has been 93 
also described that BAT from obese and hyperglycemic mice shows higher levels of oxidative 94 
damage and inflammation (macrophages and T cells infiltration) [11]. Thus, tremendous efforts 95 
are being made by the research community to enhance BAT thermogenesis and fight against 96 
obesity and its associated metabolic diseases. 97 
 98 
2. Classification and distribution of brown adipose tissue  99 
2.1. Types of adipose cells and function: white, brown, beige and pink  100 
In addition to being the largest energy reservoir in the body, adipose tissue is a complex 101 




































































functions, inflammation and immunity. It also regulates whole-body energy homeostasis with a 103 
relevant role in glucose and lipid metabolism [12].  104 
Adipose tissue is mostly composed of adipocytes. However, other cell types can be found 105 
grouped in the stromal vascular fraction (SVF). They include preadipocytes, fibroblasts, 106 
mesenchymal stem cells (MSCs), endothelial cells, and immune cells such as T cells, B cells, 107 
macrophages, and dendritic cells [13]. Differentiated adipocytes are mostly composed of lipid 108 
droplets, since their main function is the storage of energy in the form of triglycerides. There are 109 
several adipose cell types that differ in their morphology, gene expression and metabolic 110 
functions. Despite some controversy, they are commonly named white, brown, beige and pink 111 
adipocytes. 112 
Morphologically, white adipocytes present a large unilocular lipid droplet that takes up most of 113 
the intracellular space, displacing the rest of the organelles to the periphery. These adipocytes 114 
are found in white adipose tissue (WAT), which is the main lipid storage organ, providing 115 
energy during postprandial fasting and thus regulating energy homeostasis. WAT is also an 116 
endocrine organ secreting hormones such as leptin, adiponectin, and resistin, and cytokines such 117 
as tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) [14]. It is characterized by some 118 
genetic markers such as lipoprotein lipase (LPL) or glycerol 3-phosphate dehydrogenase 119 
(G3PHD) [15], surface transporter ASC-1 [16], and the specific transcription factor Tcf21 [17].  120 
In contrast to white adipocytes, brown adipocytes present small multilocular lipid droplets and 121 
are composed of many mitochondria that give the BAT its characteristic color. In response to 122 
cold exposure, brown adipocytes maintain body temperature by dissipating energy in the form of 123 
heat in a process known as non-shivering thermogenesis. This process is carried out by 124 
uncoupling protein 1 (UCP1) in response to sympathetic nervous system adrenergic stimulation. 125 
Thus, UCP1 generates heat by uncoupling electron transport from ATP production. UCP1 as 126 




































































Beige or brite (brown-in-white) adipocytes have intermediate characteristics between white and 128 
brown adipocytes in terms of morphology (number of lipid droplets and mitochondria) and 129 
UCP1 expression [19]. Beige adipocytes arise from WAT in response to cold temperature or -130 
adrenergic exposure, through a reversible process called browning or beiging. This process 131 
implies increased thermogenesis within the WAT, i.e. augmented UCP1 expression and activity 132 
in the WAT depots. At least two mechanisms have been hypothesized to occur during the 133 
browning process: 1) the transdifferentiation or conversion of white into beige adipocytes, and 2) 134 
de novo brown adipogenesis. The transdifferentiation has been described in several studies [20–135 
23]. Supporting the second hypothesis, Lee et al. have reported a -adrenergic-induced 136 
proliferation and further differentiation of precursors present in WAT [24]. Although further 137 
research is needed in this area, most likely the two processes might take place at the same time 138 
and to different degrees according to the fat depot or the stimuli received. Besides natural 139 
inducers of browning such as cold or exercise, a large number of browning agents have been 140 
described [6]. In addition to intermediate expression of UCP1, beige adipocytes express the 141 
surface markers PAT2 and P2RX5 [16,25] and the specific markers Cd137, Epsti1, Tbx1, and 142 
transmembrane protein 26 (Tmem26) [17,18,26]. 143 
Ultimately, a last adipocyte cell type has been described to arise from white adipocyte depots 144 
during the gestation and lactation period: pink adipocytes. Their main function is to secrete milk 145 
and to store large amounts of lipids in the mammary gland during this period. Differentiation to 146 
pink adipocytes is reversed once lactation ends, together with the involution of the mammary 147 
glands [27,28]. Pink adipocytes are characterized by the expression of leptin and S-100b [29]. 148 
 149 
2.2. Distribution in rodents and humans 150 
Adipose tissue is widely distributed in mammals around the entire body. There are two types of 151 




































































commonly classified into two types: visceral WAT that is located in the abdomen surrounding 153 
all organs or viscera, and subcutaneous WAT (scWAT) that is found under the skin [30]. BAT 154 
was thought to be exclusive to rodents and human neonates, but in the last decade it was found 155 
to be active in adult humans as well [1–5,7,8]. In adult humans, classical BAT is located in the 156 
supraclavicular region, but other locations are also found around the neck, axillary, paravertebral 157 
and perirenal areas (Figure 1) [8,31].  158 
To obtain a better approximation of the locations of the various adipose tissues, non-invasive 159 
techniques are used to determine which of the tissues are thermogenically active. The most 160 
widely used substrate is a glucose analog called 2-deoxy-2-[
18
F]fluorodeoxyglucose that can be 161 
detected by positron emission tomography/computed tomography (PET/CT) [32–35]. In a recent 162 
study, images obtained by [
18
F]fluorodeoxyglucose-PET/CT as well as [
123/125
I]-beta-methyl-p-163 
iodophenyl-pentadecanoic-SPECT/CT were compared to identify tissue with high glucose or FA 164 
uptake, respectively [36]. By using both methods with and without thermogenesis induction by 165 
cold stimulation or a β-adrenergic agonist, thermogenically active areas were detected in mice 166 
and humans in all adipose tissues, except epididymal white adipose tissue (eWAT). These results 167 
are consistent with the typical morphology observed by histological examination and with the 168 
expression of specific genes measured in each of the identified tissues. Ultimately, the authors 169 
conclude that in mice the supraclavicular, anterior cervical, axillary, infrascapular, supraspinal 170 
and ventral spinal adipose tissues correspond to classical BAT. The eWAT would correspond to 171 
classical WAT, and finally the anterior subcutaneous and suprascapular adipose tissues would be 172 
encompassed within WAT with a capacity to generate beige adipocytes after exposure to cold or 173 
-adrenergic induction. Finally, a recent, elegant study proposes a non-invasive method to 174 
measure in vivo local BAT metabolism [37]. Reber and colleagues use an optoacoustic imaging 175 
method to measure hemoglobin gradients in mouse and human BAT. The measurements of 176 




































































measured during BAT metabolic activation was performed at the same time as the optoacoustic 178 
measurements of hemoglobin. The results were consistent with those obtained by PET and could 179 
discern between tissues from healthy and diabetic subjects [37].  180 
 181 
2.3. Origin and development of brown adipocytes 182 
Adipose cells have a mesodermal origin and derive from MSCs (Figure 2) [38,39]. MSCs are 183 
adherent cells that express various surface markers such as CD29, CD44, CD73, CD90, CD105, 184 
CD166, and Stro-1 [40]. Furthermore, MSCs are multipotent cells, i.e. in addition to their 185 
capacity to generate mature adipocytes, they can differentiate into other cell types such as 186 
chondrocytes, osteoblasts, myoblast cells, or connective tissue [39,41].  187 
Brown adipocytes and myoblasts arise from myogenic cell lineage progenitors that express the 188 
myogenic transcription factor Myf5+. A recent study demonstrates that the transcription factors 189 
MyoD and Myf5 are key players in the repression or activation of the transcription factor 190 
PRDM16, determining the differentiation of the brown adipose lineage [42]. In contrast to 191 
brown adipocytes, white adipocytes arise from Myf5- precursors. In addition, the expression of 192 
transcription factor Tcf21 in these preadipocytes promotes differentiation into the white lineage, 193 
inhibiting the myogenic lineage [43]. The origin of beige adipocytes remains unclear. Despite 194 
some controversy, it is believed that they are derived from the same precursor as white 195 
adipocytes, from Myf5- progenitors, or that they are transdifferentiated from pre-existing white 196 
adipocytes. However, some studies suggest that both beige and white adipocytes may be derived 197 
from positive and negative Myf5 progenitors, and claim that some white adipocytes can be 198 
differentiated into beige after stimulation, while classic white adipocytes cannot [44,45].  199 
Bone morphogenic proteins (BMPs) are a family of proteins thought to be related to the 200 
development of adipocyte types. Several studies show that the expression of BMP7 induces an 201 




































































addition to being committed to the white lineage, BMP4 is related to the beige lineage, since its 203 
overexpression increases UCP1 levels. These results are more notorious in MSCs derived from 204 
mouse than from humans [47].  205 
Another important family of transcription factors involved in the maturation and activity of the 206 
three types of adipocytes are the Peroxisome Proliferator-Activated Receptors (PPARs). 207 
Importantly, the nuclear receptor PPARγ is essential for adipogenesis [39,43,44] and it is 208 
implicated in β-adrenergic-induced BAT thermogenesis [48]. The proliferator-activated receptor 209 
c coactivator 1 α (PGC1α) is another important regulator of BAT metabolism that is highly 210 
activated after cold exposure, increasing the activity of some transcription factors including 211 
PPARs [49]. Moreover, PGC1 promotes mitochondrial biogenesis and respiration, fatty acid 212 
oxidation and UCP1 activity in BAT [49,50]. 213 
 214 
3. Importance of brown adipose tissue in metabolism 215 
The main function of BAT is to control thermogenesis by uncoupling oxidative phosphorylation 216 
from ATP production, which generates heat. This fundamental process for survival in mammals 217 
is closely related to several metabolic pathways such as lipolysis, lipogenesis, mitochondrial 218 
respiration, or FA uptake, transport, storage, and oxidation [6]. Thermogenesis in BAT is under 219 
the tight control of the central nervous system [51]. Cold stimulates the sympathetic nervous 220 
system and the release of norepinephrine, which ultimately enhances thermogenesis via the 221 
activation of UCP1. Since BAT requires plentiful FAs, which are its primary substrate, lipolysis 222 
is activated during BAT thermogenesis [9,52,53]. The resulting FAs could be transported into 223 
the mitochondria for fuel oxidation, be involved in the regulation of UCP1, or directly activate 224 
UCP1 [52]. Interestingly, recent studies have proven that heat can be produced in BAT without 225 
intracellular lipolysis [54–56]. FAs could be obtained from 1) endogenous BAT lipolysis, 2) 226 




































































4) de novo FA synthesis. Although the classical model states that UCP1 is activated by FAs 228 
released upon lipid droplet breakdown in the BAT, Schreiber et al. and Shin et al. recently 229 
studied mice models with BAT-specific elimination of norepinephrine-induced lipolysis and 230 
showed that the mice are not cold sensitive when food is present. Thus, these studies propose a 231 
new model in which WAT lipolysis (and not BAT lipolysis) might be essential for cold-induced 232 
thermogenesis.  233 
The pathophysiology of obesity-induced metabolic disorders has been attributed to several 234 
mechanisms such as ectopic fat deposition [57] and WAT dysfunction including increased 235 
inflammation [58], endoplasmic reticulum and oxidative stress [59,60], hypoxia [61], 236 
mitochondrial dysfunction [62], fibrosis and impaired adipocyte expansion, and angiogenesis 237 
[63–66]. While the above mechanisms have been described in WAT, some studies have recently 238 
reported BAT derangements during obesity progression. High-fat diet (HFD) treatment has been 239 
shown to alter the molecular networks in BAT in a time-dependent manner [67] and to increase 240 
BAT inflammation, oxidative stress, and mitochondrial respiration in mice [11].  241 
In the last decade, the scientific community has put a spotlight on BAT as a key player in the 242 
control of energy metabolism. In fact, BAT is an active endocrine organ [1–8]. High 243 
expectations for the treatment of obesity-induced diseases have emerged with the finding that 244 
adult humans have active BAT and that its activity is reduced with age, obesity or diabetes [1–245 
5,7,8,68]. This indicates that BAT plays a key role in both cold-induced and diet-induced 246 
thermogenesis. Importantly, several studies in experimental animals have shown that BAT can 247 
dissipate caloric energy and reduce both obesity and diabetes [1–5,69–72]. In fact, after short-248 
term cold exposure, BAT is the main lipid clearance organ and it has the highest FA oxidation 249 
rate [73,74]. Thus, keeping BAT active and continuously combusting excess food energy might 250 
be a potential new approach to treat obesity-induced disorders. Titanic efforts are being made by 251 




































































thermogenesis such as cold or exercise, several factors have been found (extensively reviewed 253 
elsewhere [75,76]) to enhance thermogenesis such as FGF21 [77], BMP7 [78], BMP8b [79], 254 
natriuretic peptides [80], norepinephrine [81], meteorin-like [82], bile acids [83], or adenosine 255 
[84]. Interestingly, a drug that can enhance BAT thermogenesis has been tested in humans for 256 
the first time [85]. Cypess et al. administered orally the 3-adrenergic receptor agonist 257 
mirabegron in healthy young humans. The compound stimulated BAT thermogenesis and 258 
increased resting metabolic rate. However, further research is needed to study mirabegron’s 259 
mechanism of action and potential off-target effects [86].  260 
 261 
4. Source of mesenchymal stem cells in rodents and humans 262 
The population of stem cells has always been associated with embryonic stem cells and stem 263 
cells isolated from the bone marrow. However, other potential sources of stem cells in human 264 
adults have been identified in recent years (Figure 2). 265 
The umbilical cord and peripheral blood are the most studied sources, due to non-invasive, easy 266 
isolation methods. Adipose tissue is also considered a good option, as a high number of MSCs is 267 
obtained. Apart from these, there are many other tissues from which MSCs can be extracted, 268 
such as bone marrow, cartilage, tendon, muscle, or dental pulp, but they require more invasive 269 
procedures [87]. Other studies focus on trying to isolate MSCs from bodily fluids such as 270 
synovial fluid [88], Wharton’s jelly [89] or even menstrual blood [90].  271 
In a recent study, stem cells isolated from umbilical cord blood and WAT obtained from 272 
liposuction were compared [91]. Both cell types were differentiated into white and brown 273 
adipocytes. The results showed that adipose tissue-derived MSCs (AT-MSCs) had a greater 274 
capacity for adipocyte differentiation, and higher UCP1 expression when differentiated into 275 
brown adipocytes [91]. The authors concluded that adipose tissue is a more appropriate source of 276 




































































Cell transdifferentiation studies are also being carried out to obtain stem cells from differentiated 278 
cells for future therapeutic uses. In one of these studies related to adipose tissue, the authors 279 
transdifferentiated human mature white adipocytes into fibroblast-like cells that maintained stem 280 
cell gene signatures [92].  281 
The source and method of obtaining MSCs can be very similar in rodents and humans. However, 282 
the time required and the capacity for differentiation to other lineages can vary between species, 283 
hindering their translation to future therapeutic applications [93]. 284 
 285 
5. Effects of thermogenic adipocyte transplantation in obesity 286 
5.1. Beige or brown cell transplantation 287 
The potential efficacy of AT-MSCs to prevent obesity and other associated pathologies has been 288 
proven in several studies summarized in Table 1. Silva et al. isolated AT-MSCs from human 289 
mediastinal brown fat depots and carried out several studies in non-obese diabetic/severe 290 
combined immunodeficiency (NOD/SCID) mice fed a HFD to evaluate their thermogenic 291 
potential in vivo [94]. While no differences were seen when undifferentiated AT-MSCs were 292 
injected subcutaneously compared to saline controls, the authors observed a reduction in body 293 
weight and glucose levels in mice that had been transplanted with differentiated AT-MSCs 294 
within scaffolds 5 weeks post-transplantation [94]. Similar results were obtained in another 295 
study in which human-derived MSCs, MSC-derived brown adipocytes, and MSC lysate were 296 
injected intraperitoneally into obese mice for 10 weeks [95]. Only the injection of MSC-derived 297 
brown adipocytes reduced body weight and decreased triglyceride and cholesterol levels. 298 
However, all treatments improved non-alcoholic fatty liver disease, non-alcoholic 299 
steatohepatitis, glucose intolerance, inflammation, and energy homeostasis. 300 
Functional brown adipocytes have also been generated by cellular reprogramming procedures 301 




































































PRDM16 gene or from direct conversion of mouse embryonic fibroblasts (dBAs) by the 303 
induction of PRDM16, C/EBP-β and L-MYC genes [96]. Importantly, subcutaneous 304 
transplantation of brown adipocytes (obtained from iBAs or dBAs) in HFD-treated mice and in 305 
KK-Ay diabetic mice was able to reduce diet-induced obesity, dyslipidemia, and insulin 306 
resistance [96]. 307 
In addition to the implantation of brown adipocytes, an elegant study shows another potential 308 
therapy against obesity through the thermogenic induction of human white adipocytes with 309 
adrenergic stimuli [97]. Beige adipocytes were derived from human capillary network 310 
progenitors and activated in vitro with the adenylate cyclase activator forskolin. These cells 311 
showed increased UCP1 mRNA expression and enhanced systemic glucose tolerance when 312 
implanted with matrigel subcutaneously into glucose-intolerant NOD-scid IL2rg(null) mice, both 313 
in normal chow or HFD [97]. 314 
 315 
5.2. Brown adipose tissue transplantation 316 
In addition to the transplantation of beige or brown adipocytes, several studies have directly 317 
implanted BAT in an attempt to combat metabolic disorders (Table 1). To date, most BAT 318 
transplants have been performed in mice. Usually, the tissue originates from healthy adult wild-319 
type donor mice and is implanted into a recipient mouse model for different purposes. 320 
One of the first studies targeting diabetes was carried out in a streptozotocin-induced type I 321 
diabetes mouse model where BAT was transplanted from healthy mouse embryos 322 
subcutaneously [98]. One month after transplantation, mice showed normal blood glucose levels, 323 
an increase in adiponectin and leptin levels, and a reduction in adipose tissue weight and 324 
inflammation markers. Importantly, diabetic markers such as polyuria, polydipsia and 325 
polyphagia were reversed. However, insulin resistance and blood insulin levels were unchanged 326 




































































mouse model in which BAT transplantation prevented diabetes [99]. They highlighted insulin-328 
like growth factor-I (IGF-I) as an enhancer of these adipogenic, anti-inflammatory, and anti-329 
diabetic effects [99].  330 
In obesity-related studies, BAT transplantation is commonly carried out to reduce metabolic 331 
derangements associated with high calorie intake. Several studies performed BAT transplants in 332 
HFD-induced obese mice, in locations such as the visceral cavity, adjacent to endogenous BAT, 333 
or even the subcutaneous space, to determine whether this metabolically active organ can reverse 334 
obesity-induced metabolic disorders [100–102]. All these studies observed an improvement in 335 
glucose levels, an increase in insulin sensitivity, and a decrease in inflammation. In addition, 336 
these results were accompanied by an increase in levels of hormones such as adiponectin or 337 
norepinephrine, resulting in a higher metabolic rate, oxygen consumption, and energy 338 
expenditure [100–102]. 339 
As mentioned above, exposure to cold, a -adrenergic stimulus, or exercise could induce 340 
browning in WAT resulting in beige fat. Stanford et al. transplanted scWAT from exercise-341 
trained donors into the visceral cavity of HFD-treated sedentary recipients [103]. The authors 342 
demonstrated that exercise-induced beige fat transplantation can improve glucose homeostasis 343 
and the HFD-induced metabolic phenotype by increasing the oxygen consumption rate and 344 
UCP1 mRNA levels of the transplanted scWAT [103]. 345 
Other authors have studied the therapeutic potential of BAT in genetically modified animal 346 
models. In 2015, BAT from wild-type mice was transplanted subcutaneously in the dorsal region 347 
of leptin-deficient obese mice (ob/ob) [70]. The results obtained in this model corroborated those 348 
found in previous studies [100–102]: decreased weight gain, increased energy expenditure, and 349 
improved insulin sensitivity and hepatic steatosis. In addition, the authors reported an increase in 350 
adiponectin levels, expression of the 3-adrenergic receptor, and WAT FA oxidation [70]. 351 




































































BH4 is involved in the control of BAT’s regulatory factors such as norepinephrine and nitric 353 
oxide. Hph-1 mice are obese, glucose intolerant, insulin resistant, and have impaired BAT 354 
function. Implantation of BAT from wild-type donors into the visceral fat region of Hph-1 mice 355 
improved BAT function together with systemic metabolic alterations [104]. BAT transplantation 356 
has also been used to study a mouse model of Parkinson’s disease by using DJ-1 knockout mice 357 
[105]. 358 
Metabolic activation after BAT transplantation has also been studied in other obesity-associated 359 
pathologies, such as cardiovascular disease, polycystic ovary syndrome, and atherosclerosis. 360 
Thoonen et al. utilized UCP1-deficient mice subjected to catecholamine-induced 361 
cardiomyopathy [106]. BAT transplantation from wild-type donors into the visceral cavity of 362 
UCP1-deficient mice improved survival and reduced myocardial injury, indicating a systemic 363 
cardioprotective role of functional BAT [106]. In a rat model with dehydroepiandrosterone 364 
(DHEA)-induced polycystic ovarian syndrome, BAT from wild-type rat donors was implanted in 365 
the dorsal region adjacent to endogenous BAT [107]. In addition to reversion of the DHEA-366 
induced polycystic ovary syndrome characteristics, the authors observed metabolic 367 
improvements in glucose tolerance and insulin sensitivity [107]. Finally, BAT but not 368 
epididymal WAT (eWAT) transplantation reduced ApoE knockout-induced atherosclerosis in 369 
mice [108]. The authors concluded that this was mediated by metabolic improvements such as 370 
an increase in oxygen consumption, energy expenditure, and FGF-21, norepinephrine, and 371 
adiponectin levels; improvement in glucose tolerance; and a reduction in triglyceride levels 372 
[108]. Importantly, serum TNF levels were increased after BAT transplantation and the 373 
implanted BAT showed higher levels of several pro- and anti-inflammatory mediators such as 374 
TNF, IL-6, MCP-1, PAI-1, IGF-1, TFG-, IL-4 and IL-10. This raises the question of whether 375 
the immune cells present in the circulation and/or in the implanted BAT would compromise in 376 





































































6. Discussion 379 
BAT is a metabolically active organ, involved in the maintenance of energy homeostasis. 380 
Therefore, it is an attractive target in the fight against obesity and other associated metabolic 381 
diseases. The activities of brown adipocytes are reduced in obese and diabetic patients [3], which 382 
provides possibilities of targeting functional BAT that might result in therapeutic benefits. Thus, 383 
activation of BAT represents a potential opportunity to enhance energy expenditure and weight 384 
loss, and to improve lipid and glucose homeostasis.  385 
Many studies have attempted to increase WAT browning and BAT activity through the use of 386 
several activators of thermogenesis (extensively reviewed elsewhere [6,75,76]). Here, we 387 
reviewed the potential benefits of transplanting functional BAT. We covered the source of 388 
adipocytes, the methods used, and the main metabolic outcomes (Figure 3).  389 
Embryonic stem cells and stem cells isolated from bone marrow have been the traditional 390 
sources of MSCs. However, other potential stem cell sources in human adults have been 391 
described recently, such as the umbilical cord, peripheral blood, adipose tissue, bone marrow, 392 
cartilage, tendon, muscle and dental pulp [87]. The last five require more invasive procedures. 393 
However, the umbilical cord and peripheral blood are good options in terms of non-invasive, 394 
easy isolation methods. Adipose tissue is currently gaining leadership due to the fact that a large 395 
number of MSCs can be obtained, and AT-MSCs have a greater capacity for adipocyte 396 
differentiation and higher UCP1 expression when differentiated into brown adipocytes than 397 
MSCs isolated from umbilical cord blood [91]. This makes AT-MSCs a more appropriate source 398 
of MSCs for the study of obesity and other metabolic dysfunctions.  399 
Transplantation studies have used both beige/brown cells or BAT directly with proven efficacy 400 
to prevent obesity and associated pathologies (Table 1 and Figure 3). In the first case, AT-MSCs 401 




































































adrenergic stimuli to obtain functional beige or brown adipocytes [94–97]. In the second case, 403 
BAT transplantation has been performed in mouse models of diabetes, diet, and genetic models 404 
of obesity, and obesity-associated pathologies, such as cardiovascular disease, polycystic ovary 405 
syndrome, and atherosclerosis [70,98,107,108,99–106]. In the vast majority of the studies, the 406 
metabolic phenotype including glucose tolerance, insulin sensitivity, and weight gain was 407 
efficiently improved (Table 1). 408 
BAT thermogenesis is under the tight control of the brain. Thus, several authors have evaluated 409 
whether, in addition to the normal revascularization of the transplanted BAT, it was also 410 
irrigated by the sympathetic nervous system [96,101,109]. The evaluation of the re-innervation 411 
of the implant was performed by the IHC detection of tyrosine hydroxylase, an essential enzyme 412 
for the synthesis of catecholamines such as norepinephrine. These studies suggest that there is a 413 
partial sympathetic re-innervation of the transplanted BAT but to a lesser extend compared to the 414 
endogenous BAT. In addition, recipient mice showed an increase in sympathetic activity and 415 
plasma norepinephrine [101,109]. Altogether, this indicates that the implanted BAT receives the 416 
brain regulation and contributes to the sympathetic activity of the endogenous BAT. 417 
Transplantation of functional BAT has been performed mainly in mice. Thus, translation into 418 
human therapeutic studies must be carried out with caution. Although the MSCs source and 419 
isolation method could be similar in rodents and humans, there might be differences in the 420 
duration and capacity for differentiation to other lineages and the outcome obtained. In addition, 421 
the accessibility of BAT in humans is challenging due to its distribution in the body. The most 422 
likely source of AT-MSCs in humans would be WAT obtained from surgical interventions such 423 
as liposuction.  424 
Other potential limitations of the transplantation of functional BAT are related to safety. This 425 
raises the question of how tightly controlled is BAT thermogenesis. Enhanced BAT 426 




































































rate or tachycardia that might be contraindicated in the elderly or for those with heart disease. 428 
While no signs of necrosis have been reported in the transplantation studies performed in mice, 429 
increased resting metabolic rate and tachycardia has been described in humans treated with the 430 
3-adrenergic receptor agonist mirabegron [85,86]. This drug is currently approved to treat 431 
overactive bladder and was reported to activate human BAT in healthy and young humans [85]. 432 
However, the potential adverse effects should be considered in further human applications. In 433 
addition, most of the studies in mice have analysed the increased in BAT thermogenesis in a 434 
short-term period. Long-term studies would have to carefully analyse whether the increase in 435 
energy expenditure by thermogenesis triggers a compensatory mechanism such as an augmented 436 
appetite that might overcome its benefit. 437 
 438 
Disclosure statement 439 
The authors declare no conflicts of interest. 440 
 441 
Funding 442 
This work was supported by the Ministry of Spain (MINECO) (Grant SAF2017-83813-C3-1-R 443 
to DS and LH cofunded by the European Regional Development Fund [ERDF]), the Centro de 444 
Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) 445 
(Grant CB06/03/0001 to DS), and the Fundació La Marató de TV3 (Grant 87/C/2016 to DS). 446 
MCS-V is a recipient of the Ajut de Personal Investigador Predoctoral en Formació (APIF) 447 
fellowship from the University of Barcelona, SZ of the Comisión Nacional de Investigación 448 
Científica y Tecnológica (CONICYT) fellowship from Chile, and PM of the Juan de la Cierva-449 
Incorporación fellowship from MINECO. We thank Servier Medical Art Webmaster for its 450 





































































[1] K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, 453 
J. Laine, N.-J. Savisto, S. Enerbäck, P. Nuutila, Functional brown adipose tissue in 454 
healthy adults., N. Engl. J. Med. 360 (2009) 1518–25. doi:10.1056/NEJMoa0808949. 455 
[2] M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, J. Nedergaard, 456 
S. Cinti, The presence of UCP1 demonstrates that metabolically active adipose tissue in 457 
the neck of adult humans truly represents brown adipose tissue., FASEB J. 23 (2009) 458 
3113–20. doi:10.1096/fj.09-133546. 459 
[3] A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. 460 
Palmer, Y.-H. Tseng, A. Doria, G.M. Kolodny, C.R. Kahn, Identification and importance 461 
of brown adipose tissue in adult humans., N. Engl. J. Med. 360 (2009) 1509–17. 462 
doi:10.1056/NEJMoa0810780. 463 
[4] M. Saito, Y. Okamatsu-Ogura, M. Matsushita, K. Watanabe, T. Yoneshiro, J. Nio-464 
Kobayashi, T. Iwanaga, M. Miyagawa, T. Kameya, K. Nakada, Y. Kawai, M. Tsujisaki, 465 
High incidence of metabolically active brown adipose tissue in healthy adult humans: 466 
effects of cold exposure and adiposity., Diabetes. 58 (2009) 1526–31. doi:10.2337/db09-467 
0530. 468 
[5] W.D. van Marken Lichtenbelt, J.W. Vanhommerig, N.M. Smulders, J.M. a F.L. 469 
Drossaerts, G.J. Kemerink, N.D. Bouvy, P. Schrauwen, G.J.J. Teule, Cold-activated 470 
brown adipose tissue in healthy men., 2009. doi:10.1056/NEJMoa0808718. 471 
[6] L. Calderon-Dominguez, M; Mir, JF; Fucho, R; Weber, M; Serra, D; Herrero, Fatty Acid 472 
Metabolism and the Basis of Brown Adipose Tissue Function, Adipocyte. 5 (2016) 98–473 
118. 474 
[7] T.F. Hany, E. Gharehpapagh, E.M. Kamel, A. Buck, J. Himms-Hagen, G.K. Von 475 




































































neck and upper chest region, Eur. J. Nucl. Med. 29 (2002) 1393–1398. 477 
doi:10.1007/s00259-002-0902-6. 478 
[8] J. Nedergaard, T. Bengtsson, B. Cannon, Unexpected evidence for active brown adipose 479 
tissue in adult humans., Am. J. Physiol. Endocrinol. Metab. 293 (2007) E444–E452. 480 
doi:10.1152/ajpendo.00691.2006. 481 
[9] J. Nedergaard, T. Bengtsson, B. Cannon, New Powers of Brown Fat: Fighting the 482 
Metabolic Syndrome, Cell Metab. 13 (2011) 238–240. doi:10.1016/j.cmet.2011.02.009. 483 
[10] T. Yoneshiro, S. Aita, M. Matsushita, Y. Okamatsu-Ogura, T. Kameya, Y. Kawai, M. 484 
Miyagawa, M. Tsujisaki, M. Saito, Age-Related Decrease in Cold-Activated Brown 485 
Adipose Tissue and Accumulation of Body Fat in Healthy Humans, Obesity. 19 (2011) 486 
1755–1760. doi:10.1038/oby.2011.125. 487 
[11] M. Alcalá, M. Calderon-Dominguez, E. Bustos, P. Ramos, N. Casals, D. Serra, M. Viana, 488 
L. Herrero, Increased inflammation, oxidative stress and mitochondrial respiration in 489 
brown adipose tissue from obese mice., Sci. Rep. 7 (2017) 16082. doi:10.1038/s41598-490 
017-16463-6. 491 
[12] S.S. Choe, J.Y. Huh, I.J. Hwang, J.I. Kim, J.B. Kim, Adipose tissue remodeling: Its role 492 
in energy metabolism and metabolic disorders, Front. Endocrinol. (Lausanne). 7 (2016) 493 
1–16. doi:10.3389/fendo.2016.00030. 494 
[13] F. Villarroya, R. Cereijo, J. Villarroya, A. Gavaldà-Navarro, M. Giralt, Toward an 495 
Understanding of How Immune Cells Control Brown and Beige Adipobiology., Cell 496 
Metab. 27 (2018) 954–961. doi:10.1016/j.cmet.2018.04.006. 497 
[14] G. Medina-Gómez, Mitochondria and endocrine function of adipose tissue, Best Pract. 498 
Res. Clin. Endocrinol. Metab. 26 (2012) 791–804. doi:10.1016/j.beem.2012.06.002. 499 
[15] J.P. Dulor, B. Cambon, P. Vigneron, Y. Reyne, J. Nouguès, L. Casteilla, F. Bacou, 500 




































































fatty degeneration, FEBS Lett. 439 (1998) 89–92. doi:10.1016/S0014-5793(98)01216-2. 502 
[16] S. Ussar, K.Y. Lee, S.N. Dankel, J. Boucher, M.F. Haering, A. Kleinridders, T. Thomou, 503 
R. Xue, Y. Macotela, A.M. Cypess, Y.H. Tseng, G. Mellgren, C.R. Kahn, ASC-1, PAT2, 504 
and P2RX5 are cell surface markers for white, beige, and brown adipocytes, Sci. Transl. 505 
Med. 6 (2014). doi:10.1126/scitranslmed.3008490. 506 
[17] J.M. a de Jong, O. Larsson, B. Cannon, J. Nedergaard, A stringent validation of mouse 507 
adipose tissue identity markers, Am. J. Physiol. - Endocrinol. Metab. 308 (2015) E1085–508 
E1105. doi:10.1152/ajpendo.00023.2015. 509 
[18] M. Harms, P. Seale, Brown and beige fat: Development, function and therapeutic 510 
potential, Nat. Med. 19 (2013) 1252–1263. doi:10.1038/nm.3361. 511 
[19] J. Wu, P. Boström, L.M. Sparks, L. Ye, J.H. Choi, A.-H. Giang, M. Khandekar, K.A. 512 
Virtanen, P. Nuutila, G. Schaart, K. Huang, H. Tu, W.D. van Marken Lichtenbelt, J. 513 
Hoeks, S. Enerbäck, P. Schrauwen, B.M. Spiegelman, Beige adipocytes are a distinct type 514 
of thermogenic fat cell in mouse and human., Cell. 150 (2012) 366–376. 515 
doi:10.1016/j.cell.2012.05.016. 516 
[20] G. Barbatelli, I. Murano, L. Madsen, Q. Hao, M. Jimenez, K. Kristiansen, J.P. Giacobino, 517 
R. De Matteis, S. Cinti, The emergence of cold-induced brown adipocytes in mouse white 518 
fat depots is determined predominantly by white to brown adipocyte transdifferentiation., 519 
Am. J. Physiol. Endocrinol. Metab. 298 (2010) E1244–E1253. 520 
doi:10.1152/ajpendo.00600.2009. 521 
[21] G. Barbatelli, M. Morroni, P. Vinesi, S. Cinti, F. Michetti, S-100 protein in rat brown 522 
adipose tissue under different functional conditions: a morphological, 523 
immunocytochemical, and immunochemical study., Exp. Cell Res. 208 (1993) 226–31. 524 
doi:10.1006/excr.1993.1241. 525 




































































Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white 527 
adipocytes., Am. J. Physiol. Cell Physiol. 279 (2000) C670–C681. 528 
[23] M. Rosenwald, A. Perdikari, T. Rülicke, C. Wolfrum, Bi-directional interconversion of 529 
brite and white adipocytes., Nat. Cell Biol. 15 (2013) 659–67. doi:10.1038/ncb2740. 530 
[24] Y.-H. Lee, A.P. Petkova, E.P. Mottillo, J.G. Granneman, In vivo identification of 531 
bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat 532 
feeding., Cell Metab. 15 (2012) 480–91. doi:10.1016/j.cmet.2012.03.009. 533 
[25] R.A. Garcia, J.N. Roemmich, K.J. Claycombe, Evaluation of markers of beige adipocytes 534 
in white adipose tissue of the mouse, Nutr. Metab. 13 (2016) 1–14. doi:10.1186/s12986-535 
016-0081-2. 536 
[26] M. Cedikova, M. Kripnerová, J. Dvorakova, P. Pitule, M. Grundmanova, V. Babuska, D. 537 
Mullerova, J. Kuncova, Mitochondria in White, Brown, and Beige Adipocytes, Stem 538 
Cells Int. 2016 (2016). doi:10.1155/2016/6067349. 539 
[27] S. Cinti, UCP1 protein: The molecular hub of adipose organ plasticity, Biochimie. 134 540 
(2017) 71–76. doi:10.1016/j.biochi.2016.09.008. 541 
[28] A. Giordano, A. Frontini, S. Cinti, Convertible visceral fat as a therapeutic target to curb 542 
obesity, Nat. Rev. Drug Discov. 15 (2016) 405–424. doi:10.1038/nrd.2016.31. 543 
[29] A. Giordano, A. Smorlesi, A. Frontini, G. Barbatelli, S. Cint, White, brown and pink 544 
adipocytes: The extraordinary plasticity of the adipose organ, Eur. J. Endocrinol. 170 545 
(2014). doi:10.1530/EJE-13-0945. 546 
[30] D.E. Chusyd, D. Wang, D.M. Huffman, T.R. Nagy, Relationships between Rodent White 547 
Adipose Fat Pads and Human White Adipose Fat Depots, Front. Nutr. 3 (2016). 548 
doi:10.3389/fnut.2016.00010. 549 
[31] A.M. Cypess, A.P. White, C. Vernochet, T.J. Schulz, R. Xue, C.A. Sass, T.L. Huang, C. 550 




































































Truchan, A.L. Glasgow, A.R. Holman, A. Gavrila, P.-O. Hasselgren, M.A. Mori, M. 552 
Molla, Y.-H. Tseng, Anatomical localization, gene expression profiling and functional 553 
characterization of adult human neck brown fat., Nat. Med. 19 (2013) 635–9. 554 
doi:10.1038/nm.3112. 555 
[32] A. Bartelt, J. Heeren, Adipose tissue browning and metabolic health., Nat. Rev. 556 
Endocrinol. 10 (2014) 24–36. doi:10.1038/nrendo.2013.204. 557 
[33] M. Chondronikola, S. Beeman, R.L. Wahl, Non-invasive methods for the assessment of 558 
brown adipose tissue in humans, J. Physiol. 3 (2017) 363–378. doi:10.1113/JP274255. 559 
[34] J.W. Park, K.-H. Jung, J.H. Lee, C.H.T. Quach, S.-H. Moon, Y.S. Cho, K.-H. Lee, 18F-560 
FDG PET/CT Monitoring of 3 Agonist-Stimulated Brown Adipocyte Recruitment in 561 
White Adipose Tissue, J. Nucl. Med. 56 (2015) 153–158. 562 
doi:10.2967/jnumed.114.147603. 563 
[35] T.A. Jones, N.L. Reddy, S.C. Wayte, O. Adesanya, G.K. Dimitriadis, C.E. Hutchinson, 564 
T.M. Barber, Brown fat depots in adult humans remain static in their locations on PET/CT 565 
despite changes in seasonality, Physiol. Rep. 5 (2017) 1–8. doi:10.14814/phy2.13284. 566 
[36] F. Zhang, G. Hao, M. Shao, K. Nham, Y. An, Q. Wang, Y. Zhu, C.M. Kusminski, G. 567 
Hassan, R.K. Gupta, Q. Zhai, X. Sun, P.E. Scherer, O.K. Oz, An Adipose Tissue Atlas: 568 
An Image-Guided Identification of Human-like BAT and Beige Depots in Rodents, Cell 569 
Metab. 27 (2018) 252–262.e3. doi:10.1016/j.cmet.2017.12.004. 570 
[37] J. Reber, M. Willershäuser, A. Karlas, K. Paul-Yuan, G. Diot, D. Franz, T. Fromme, S. V. 571 
Ovsepian, N. Bézière, E. Dubikovskaya, D.C. Karampinos, C. Holzapfel, H. Hauner, M. 572 
Klingenspor, V. Ntziachristos, Non-invasive Measurement of Brown Fat Metabolism 573 
Based on Optoacoustic Imaging of Hemoglobin Gradients., Cell Metab. 27 (2018) 689–574 
701.e4. doi:10.1016/j.cmet.2018.02.002. 575 




































































technology in regenerative medicine and biology., Adv. Biochem. Eng. Biotechnol. 123 577 
(2010) 127–141. doi:10.1007/10. 578 
[39] S. Gesta, Y.H. Tseng, C.R. Kahn, Developmental Origin of Fat: Tracking Obesity to Its 579 
Source, Cell. 131 (2007) 242–256. doi:10.1016/j.cell.2007.10.004. 580 
[40] H J  B uhring, V.L. Battula, S. Treml, B. Schewe, L. Kanz, W. Vogel, Novel markers for 581 
the prospective isolation of human MSC, Ann. N. Y. Acad. Sci. 1106 (2007) 262–271. 582 
doi:10.1196/annals.1392.000. 583 
[41] M. Koltzscher, C. Neumann, S. Kö, V. Gerke, Human Adipose Tissue Is a Source of 584 
Multipotent Stem Cells, Mol. Biol. Cell. 14 (2003) 2372–2384. doi:10.1091/mbc.E02. 585 
[42] Y. An, G. Wang, Y. Diao, Y. Long, X. Fu, M. Weng, L. Zhou, K. Sun, T.H. Cheung, 586 
N.Y. Ip, H. Sun, H. Wang, Z. Wu, A Molecular Switch Regulating Cell Fate Choice 587 
between Muscle Progenitor Cells and Brown Adipocytes, Dev. Cell. 41 (2017) 382–588 
391.e5. doi:10.1016/j.devcel.2017.04.012. 589 
[43] J.A. Timmons, K. Wennmalm, O. Larsson, T.B. Walden, T. Lassmann, N. Petrovic, D.L. 590 
Hamilton, R.E. Gimeno, C. Wahlestedt, K. Baar, J. Nedergaard, B. Cannon, Myogenic 591 
gene expression signature establishes that brown and white adipocytes originate from 592 
distinct cell lineages., Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4401–4406. 593 
doi:10.1073/pnas.0610615104. 594 
[44] D.T. Chu, B. Gawronska-Kozak, Brown and brite adipocytes: Same function, but 595 
different origin and response, Biochimie. 138 (2017) 102–105. 596 
doi:10.1016/j.biochi.2017.04.017. 597 
[45] M. Rosenwald, C. Wolfrum, The origin and definition of brite versus white and classical 598 
brown adipocytes., Adipocyte. 3 (2014) 4–9. doi:10.4161/adip.26232. 599 
[46] M. Okla, J.H. Ha, R.E. Temel, S. Chung, BMP7 drives human adipogenic stem cells into 600 





































































[47] M. Elsen, S. Raschke, N. Tennagels, U. Schwahn, T. Jelenik, M. Roden, T. Romacho, J. 603 
Eckel, BMP4 and BMP7 induce the white-to-brown transition of primary human adipose 604 
stem cells, AJP Cell Physiol. 306 (2014) C431–C440. doi:10.1152/ajpcell.00290.2013. 605 
[48] D. Lasar, M. Rosenwald, E. Kiehlmann, M. Balaz, B. Tall, L. Opitz, M.E. Lidell, N. 606 
Zamboni, P. Krznar, W. Sun, L. Varga, P. Stefanicka, J. Ukropec, P. Nuutila, K. Virtanen, 607 
E.Z. Amri, S. Enerbäck, W. Wahli, C. Wolfrum, Peroxisome Proliferator Activated 608 
Receptor Gamma Controls Mature Brown Adipocyte Inducibility through Glycerol 609 
Kinase, Cell Rep. 22 (2018) 760–773. doi:10.1016/j.celrep.2017.12.067. 610 
[49] P. Puigserver, Z. Wu, C.W. Park, R. Graves, M. Wright, B.M. Spiegelman, A cold-611 
inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell. 92 612 
(1998) 829–839. doi:10.1016/S0092-8674(00)81410-5. 613 
[50] Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. 614 
Cinti, B. Lowell, R.C. Scarpulla, B.M. Spiegelman, Mechanisms controlling 615 
mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1, 616 
Cell. 98 (1999) 115–124. doi:10.1016/S0092-8674(00)80611-X. 617 
[51] A.J. Whittle, M. López, A. Vidal-Puig, Using brown adipose tissue to treat obesity - the 618 
central issue., Trends Mol. Med. 17 (2011) 405–11. doi:10.1016/j.molmed.2011.04.001. 619 
[52] B. Cannon, J. Nedergaard, Brown adipose tissue: function and physiological significance., 620 
Physiol. Rev. 84 (2004) 277–359. doi:10.1152/physrev.00015.2003. 621 
[53] K.L. Townsend, Y.-H. Tseng, Brown fat fuel utilization and thermogenesis., Trends 622 
Endocrinol. Metab. 25 (2014) 168–77. doi:10.1016/j.tem.2013.12.004. 623 
[54] R. Schreiber, C. Diwoky, G. Schoiswohl, U. Feiler, N. Wongsiriroj, M. Abdellatif, D. 624 
Kolb, J. Hoeks, E.E. Kershaw, S. Sedej, P. Schrauwen, G. Haemmerle, R. Zechner, Cold-625 




































































Not Brown Adipose Tissue., Cell Metab. 26 (2017) 753–763.e7. 627 
doi:10.1016/j.cmet.2017.09.004. 628 
[55] H. Shin, Y. Ma, T. Chanturiya, Q. Cao, Y. Wang, A.K.G. Kadegowda, R. Jackson, D. 629 
Rumore, B. Xue, H. Shi, O. Gavrilova, L. Yu, Lipolysis in Brown Adipocytes Is Not 630 
Essential for Cold-Induced Thermogenesis in Mice., Cell Metab. 26 (2017) 764–777.e5. 631 
doi:10.1016/j.cmet.2017.09.002. 632 
[56] B. Cannon, J. Nedergaard, What Ignites UCP1?, Cell Metab. 26 (2017) 697–698. 633 
doi:10.1016/j.cmet.2017.10.012. 634 
[57] G.I. Shulman, Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic 635 
disease., N. Engl. J. Med. 371 (2014) 1131–41. doi:10.1056/NEJMra1011035. 636 
[58] A.R. Saltiel, J.M. Olefsky, Inflammatory mechanisms linking obesity and metabolic 637 
disease., J. Clin. Invest. 127 (2017) 1–4. doi:10.1172/JCI92035. 638 
[59] G.S. Hotamisligil, Inflammation and endoplasmic reticulum stress in obesity and 639 
diabetes., Int. J. Obes. (Lond). 32 Suppl 7 (2008) S52-4. doi:10.1038/ijo.2008.238. 640 
[60] S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. 641 
Nakayama, M. Makishima, M. Matsuda, I. Shimomura, Increased oxidative stress in 642 
obesity and its impact on metabolic syndrome, J. Clin. Invest. 114 (2004) 1752–1761. 643 
doi:10.1172/JCI200421625. 644 
[61] Y.S. Lee, J. Kim, O. Osborne, D.Y. Oh, R. Sasik, S. Schenk, A. Chen, H. Chung, A. 645 
Murphy, S.M. Watkins, O. Quehenberger, R.S. Johnson, J.M. Olefsky, Increased 646 
adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance 647 
in obesity., Cell. 157 (2014) 1339–52. doi:10.1016/j.cell.2014.05.012. 648 
[62] M.E. Patti, S. Corvera, The role of mitochondria in the pathogenesis of type 2 diabetes, 649 
Endocr. Rev. 31 (2010) 364–395. doi:10.1210/er.2009-0027. 650 




































































Syndrome--an allostatic perspective., Biochim. Biophys. Acta. 1801 (2010) 338–49. 652 
doi:10.1016/j.bbalip.2009.12.006. 653 
[64] K. Sun, C.M. Kusminski, P.E. Scherer, Adipose tissue remodeling and obesity., J. Clin. 654 
Invest. 121 (2011) 2094–101. doi:10.1172/JCI45887. 655 
[65] K. Sun, I.W. Asterholm, C.M. Kusminski, A.C. Bueno, Z. V Wang, J.W. Pollard, R. a 656 
Brekken, P.E. Scherer, Dichotomous effects of VEGF-A on adipose tissue dysfunction, 657 
Proc. Natl. Acad. Sci. 109 (2012) 5874–5879. doi:10.1073/pnas.1200447109. 658 
[66] C. Crewe, Y.A. An, P.E. Scherer, The ominous triad of adipose tissue dysfunction: 659 
inflammation, fibrosis, and impaired angiogenesis., J. Clin. Invest. 127 (2017) 74–82. 660 
doi:10.1172/JCI88883. 661 
[67] R.A. McGregor, E.-Y. Kwon, S.-K. Shin, U.J. Jung, E. Kim, J.H.Y. Park, R. Yu, J.W. 662 
Yun, M.-S. Choi, Time-course microarrays reveal modulation of developmental, lipid 663 
metabolism and immune gene networks in intrascapular brown adipose tissue during the 664 
development of diet-induced obesity., Int. J. Obes. (Lond). 37 (2013) 1524–31. 665 
doi:10.1038/ijo.2013.52. 666 
[68] A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. 667 
Palmer, Y.H. Tseng, A. Doria, G.M. Kolodny, C.R. Kahn, Identification and importance 668 
of brown adipose tissue in adult humans, N Engl J Med. 360 (2009) 1509–1517. 669 
[69] Y. Zhang, Q. Xu, Y.H. Liu, X.S. Zhang, J. Wang, X.M. Yu, R.X. Zhang, C. Xue, X.Y. 670 
Yang, C.Y. Xue, Medium-Chain Triglyceride Activated Brown Adipose Tissue and 671 
Induced Reduction of Fat Mass in C57BL/6J Mice Fed High-fat Diet., Biomed. Environ. 672 
Sci. 28 (2015) 97–104. doi:10.3967/bes2015.012. 673 
[70] X. Liu, S. Wang, Y. You, M. Meng, Z. Zheng, M. Dong, J. Lin, Q. Zhao, C. Zhang, X. 674 
Yuan, T. Hu, L. Liu, Y. Huang, L. Zhang, D. Wang, J. Zhan, H. Jong Lee, J.R. Speakman, 675 




































































Endocrinology. 156 (2015) 2461–9. doi:10.1210/en.2014-1598. 677 
[71] K.M. Heppner, S. Marks, J. Holland, N. Ottaway, D. Smiley, R. Dimarchi, D. Perez-678 
Tilve, Contribution of brown adipose tissue activity to the control of energy balance by 679 
GLP-1 receptor signalling in mice., Diabetologia. 58 (2015) 2124–32. 680 
doi:10.1007/s00125-015-3651-3. 681 
[72] A.R. Thiam, R. V Farese, T.C. Walther, The biophysics and cell biology of lipid droplets., 682 
Nat. Rev. Mol. Cell Biol. 14 (2013) 775–86. doi:10.1038/nrm3699. 683 
[73] A. Bartelt, O.T. Bruns, R. Reimer, H. Hohenberg, H. Ittrich, K. Peldschus, M.G. Kaul, 684 
U.I. Tromsdorf, H. Weller, C. Waurisch, A. Eychmüller, P.L.S.M. Gordts, F. Rinninger, 685 
K. Bruegelmann, B. Freund, P. Nielsen, M. Merkel, J. Heeren, Brown adipose tissue 686 
activity controls triglyceride clearance., Nat. Med. 17 (2011) 200–5. 687 
doi:10.1038/nm.2297. 688 
[74] K.-O. Doh, Y.-W. Kim, S.-Y. Park, S.-K. Lee, J.S. Park, J.-Y. Kim, Interrelation between 689 
long-chain fatty acid oxidation rate and carnitine palmitoyltransferase 1 activity with 690 
different isoforms in rat tissues., Life Sci. 77 (2005) 435–443. 691 
doi:10.1016/j.lfs.2004.11.032. 692 
[75] J. Wu, P. Cohen, B.M. Spiegelman, Adaptive thermogenesis in adipocytes: Is beige the 693 
new brown?, Genes Dev. 27 (2013) 234–250. doi:10.1101/gad.211649.112. 694 
[76] M.L. Bonet, P. Oliver, A. Palou, Pharmacological and nutritional agents promoting 695 
browning of white adipose tissue, Biochim. Biophys. Acta - Mol. Cell Biol. Lipids. 1831 696 
(2013) 969–985. doi:10.1016/j.bbalip.2012.12.002. 697 
[77] E. Hondares, M. Rosell, F.J. Gonzalez, M. Giralt, R. Iglesias, F. Villarroya, Hepatic 698 
FGF21 Expression Is Induced at Birth via PPARalpha in Response to Milk Intake and 699 
Contributes to Thermogenic Activation of Neonatal Brown Fat, Cell Metab. 11 (2010) 700 




































































[78] M.R. Boon, S.A.A. van den Berg, Y. Wang, J. van den Bossche, S. Karkampouna, M. 702 
Bauwens, M. De Saint-Hubert, G. van der Horst, S. Vukicevic, M.P.J. de Winther, L.M. 703 
Havekes, J.W. Jukema, J.T. Tamsma, G. van der Pluijm, K.W. van Dijk, P.C.N. Rensen, 704 
BMP7 activates brown adipose tissue and reduces diet-induced obesity only at 705 
subthermoneutrality., PLoS One. 8 (2013) e74083. doi:10.1371/journal.pone.0074083. 706 
[79] A.J. Whittle, S. Carobbio, L. Martins, M. Slawik, E. Hondares, M.J. Vázquez, D. Morgan, 707 
R.I. Csikasz, R. Gallego, S. Rodriguez-Cuenca, M. Dale, S. Virtue, F. Villarroya, B. 708 
Cannon, K. Rahmouni, M. López, A. Vidal-Puig, BMP8B increases brown adipose tissue 709 
thermogenesis through both central and peripheral actions, Cell. 149 (2012) 871–885. 710 
doi:10.1016/j.cell.2012.02.066. 711 
[80] M. Bordicchia, D. Liu, E.Z. Amri, G. Ailhaud, P. Dessi-Fulgheri, C. Zhang, N. Takahashi, 712 
R. Sarzani, S. Collins, Cardiac natriuretic peptides act via p38 MAPK to induce the brown 713 
fat thermogenic program in mouse and human adipocytes, J Clin Invest. 122 (2012) 714 
1022–1036. 715 
[81] F. Villarroya, A. Vidal-Puig, Beyond the sympathetic tone: The new brown fat activators, 716 
Cell Metab. 17 (2013) 638–643. doi:10.1016/j.cmet.2013.02.020. 717 
[82] R.R. Rao, J.Z. Long, J.P. White, K.J. Svensson, J. Lou, I. Lokurkar, M.P. Jedrychowski, 718 
J.L. Ruas, C.D. Wrann, J.C. Lo, D.M. Camera, J. Lachey, S. Gygi, J. Seehra, J.A. Hawley, 719 
B.M. Spiegelman, Meteorin-like is a hormone that regulates immune-adipose interactions 720 
to increase beige fat thermogenesis, Cell. 157 (2014) 1279–1291. 721 
doi:10.1016/j.cell.2014.03.065. 722 
[83] M. Watanabe, S.M. Houten, C. Mataki, M.A. Christoffolete, B.W. Kim, H. Sato, N. 723 
Messaddeq, J.W. Harney, O. Ezaki, T. Kodama, K. Schoonjans, A.C. Bianco, J. Auwerx, 724 
Bile acids induce energy expenditure by promoting intracellular thyroid hormone 725 




































































[84] T. Gnad, S. Scheibler, I. von Kügelgen, C  Scheele, A  Kilić, A  Glöde, L S  Hoffmann, L  727 
Reverte-Salisa, P. Horn, S. Mutlu, A. El-Tayeb, M. Kranz, W. Deuther-Conrad, P. Brust, 728 
M.E. Lidell, M.J. Betz, S. Enerbäck, J. Schrader, G.G. Yegutkin, C.E. Müller, A. Pfeifer, 729 
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A 730 
receptors., Nature. 516 (2014) 395–9. doi:10.1038/nature13816. 731 
[85] A.M. Cypess, L.S. Weiner, C. Roberts-Toler, E. Franquet Elía, S.H. Kessler, P.A. Kahn, 732 
J. English, K. Chatman, S.A. Trauger, A. Doria, G.M. Kolodny, Activation of human 733 
brown adipose tissue by a β3-adrenergic receptor agonist., Cell Metab. 21 (2015) 33–8. 734 
doi:10.1016/j.cmet.2014.12.009. 735 
[86] N. Dehvari, E.D. da Silva Junior, T. Bengtsson, D.S. Hutchinson, Mirabegron: potential 736 
off target effects and uses beyond the bladder, Br. J. Pharmacol. (2018). 737 
doi:10.1111/bph.14121. 738 
[87] D. Mushahary, A. Spittler, C. Kasper, V. Weber, V. Charwat, Isolation, cultivation, and 739 
characterization of human mesenchymal stem cells, Cytom. Part A. (2017) 19–31. 740 
doi:10.1002/cyto.a.23242. 741 
[88] T. Morito, T. Muneta, K. Hara, Y.J. Ju, T. Mochizuki, H. Makino, A. Umezawa, I. 742 
Sekiya, Synovial fluid-derived mesenchymal stem cells increase after intra-articular 743 
ligament injury in humans, Rheumatology. 47 (2008) 1137–1143. 744 
doi:10.1093/rheumatology/ken114. 745 
[89] H.-S. Wang, S.-C. Hung, S.-T. Peng, C.-C. Huang, H.-M. Wei, Y.-J. Guo, Y.-S. Fu, M.-C. 746 
Lai, C.-C  Chen, Mesenchymal Stem Cells in the Wharton’s Jelly of the Human Umbilical 747 
Cord, Stem Cells. 22 (2004) 1330–1337. doi:10.1634/stemcells.2004-0013. 748 
[90] J.G. Allickson, A. Sanchez, N. Yefimenko, C. V Borlongan, P.R. Sanberg, NIH Public 749 
Access, 3 (2011) 4–10. doi:10.2174/1876893801103010004.Recent. 750 




































































analysis of human UCB and adipose tissue derived mesenchymal stem cells for their 752 
differentiation potential into brown and white adipocytes, Mol. Biol. Rep. 0 (2018) 0. 753 
doi:10.1007/s11033-018-4156-1. 754 
[92] G. Maurizi, A. Poloni, D. Mattiucci, S. Santi, A. Maurizi, V. Izzi, A. Giuliani, S. Mancini, 755 
M.C. Zingaretti, J. Perugini, I. Severi, M. Falconi, M. Vivarelli, M.R. Rippo, S. Corvera, 756 
A  Giordano, P  Leoni, S  Cinti, Human White Adipocytes Convert Into “Rainbow” 757 
Adipocytes In Vitro, J. Cell. Physiol. 232 (2017) 2887–2899. doi:10.1002/jcp.25743. 758 
[93] A  Scuteri, E  Donzelli, D  Foudah, C  Caldara, J  Redondo, G  D’Amico, G  Tredici, M  759 
Miloso, Mesengenic differentiation: Comparison of human and rat bone marrow 760 
mesenchymal stem cells, Int. J. Stem Cells. 7 (2014) 127–134. 761 
doi:10.15283/ijsc.2014.7.2.127. 762 
[94] F.J. Silva, D.J. Holt, V. Vargas, J. Yockman, S. Boudina, D. Atkinson, D.W. Grainger, 763 
M.P. Revelo, W. Sherman, D. a Bull, A.N. Patel, Metabolically active human brown 764 
adipose tissue derived stem cells., Stem Cells. 32 (2014) 572–81. doi:10.1002/stem.1595. 765 
[95] C.-W. Lee, W.-T. Hsiao, O.K.-S. Lee, Mesenchymal stromal cell-based therapies reduce 766 
obesity and metabolic syndromes induced by a high-fat diet, Transl. Res. 182 (2017) 61–767 
74.e8. doi:10.1016/j.trsl.2016.11.003. 768 
[96] T. Kishida, A. Ejima, K. Yamamoto, S. Tanaka, T. Yamamoto, O. Mazda, Reprogrammed 769 
Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-770 
Induced Obesity and Type 2 Diabetes, Stem Cell Reports. 5 (2015) 569–581. 771 
doi:10.1016/j.stemcr.2015.08.007. 772 
[97] S.Y. Min, J. Kady, M. Nam, R. Rojas-Rodriguez, A. Berkenwald, J.H. Kim, H.-L. Noh, 773 
J K  Kim, M P  Cooper, T  Fitzgibbons, M A  Brehm, S  Corvera, Human “brite/beige” 774 
adipocytes develop from capillary networks, and their implantation improves metabolic 775 




































































[98] S.C. Gunawardana, D.W. Piston, Reversal of type 1 diabetes in mice by brown adipose 777 
tissue transplant, Diabetes. 61 (2012) 674–682. doi:10.2337/db11-0510. 778 
[99] S.C. Gunawardana, D.W. Piston, Insulin-independent reversal of type 1 diabetes in 779 
nonobese diabetic mice with brown adipose tissue transplant, Am. J. Physiol. - 780 
Endocrinol. Metab. 308 (2015) E1043–E1055. doi:10.1152/ajpendo.00570.2014. 781 
[100] K.I. Stanford, R.J.W. Middelbeek, K.L. Townsend, D. An, E.B. Nygaard, K.M. Hitchcox, 782 
K.R. Markan, K. Nakano, M.F. Hirshman, Y.-H. Tseng, L.J. Goodyear, Brown adipose 783 
tissue regulates glucose homeostasis and insulin sensitivity., J. Clin. Invest. 123 (2013) 784 
215–23. doi:10.1172/JCI62308. 785 
[101] Z. Zhu, E.G. Spicer, C.K. Gavini, A.J. Goudjo-Ako, C.M. Novak, H. Shi, Enhanced 786 
sympathetic activity in mice with brown adipose tissue transplantation (transBATation), 787 
Physiol. Behav. 125 (2014) 21–29. doi:10.1016/j.physbeh.2013.11.008. 788 
[102] X. Liu, Z. Zheng, X. Zhu, M. Meng, L. Li, Y. Shen, Q. Chi, D. Wang, Z. Zhang, C. Li, Y. 789 
Li, Y. Xue, J.R. Speakman, W. Jin, Brown adipose tissue transplantation improves whole-790 
body energy metabolism., Cell Res. 23 (2013) 851–4. doi:10.1038/cr.2013.64. 791 
[103] K.I. Stanford, R.J.W. Middelbeek, K.L. Townsend, M.Y. Lee, H. Takahashi, K. So, K.M. 792 
Hitchcox, K.R. Markan, K. Hellbach, M.F. Hirshman, Y.H. Tseng, L.J. Goodyear, A 793 
novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose 794 
homeostasis, Diabetes. 64 (2015) 2002–2014. doi:10.2337/db14-0704. 795 
[104] Y. Oguri, Y. Fujita, A. Abudukadier, A. Ohashi, T. Goto, F. Furuya, A. Obara, T. 796 
Fukushima, N. Matsuo, M. Kim, M. Hosokawa, T. Kawada, H. Hasegawa, N. Inagaki, 797 
Tetrahydrobiopterin activates brown adipose tissue and regulates systemic energy 798 
metabolism, JCI Insight. 2 (2017) 1–19. doi:10.1172/jci.insight.91981. 799 
[105] R. Wu, X.M. Liu, J.G. Sun, H. Chen, J. Ma, M. Dong, S. Peng, J.Q. Wang, J.Q. Ding, 800 




































































homeostasis by regulating the function of brown adipose tissue, Cell Discov. 3 (2017) 1–802 
18. doi:10.1038/celldisc.2016.54. 803 
[106] R. Thoonen, L. Ernande, J. Cheng, Y. Nagasaka, A. Miranda-bezerra, C. Chen, W. Chao, 804 
M. Panagia, E. David, D. Puppala, A.A. Armoundas, A. Hindle, D. Kenneth, E.S. Buys, 805 
M. Scherrer-crosbie, M.G. Hospital, A. Thorax, V. Blood, X. Hospital, C. Pain, M.G. 806 
Hospital, Functional brown adipose tissue limits cardiomyocyte injury and adverse 807 
remodeling in catecholamine-induced cardiomyopathy, (2016) 202–211. 808 
doi:10.1016/j.yjmcc.2015.05.002.Functional. 809 
[107] X. Yuan, T. Hu, H. Zhao, Y. Huang, R. Ye, J. Lin, C. Zhang, H. Zhang, G. Wei, H. Zhou, 810 
M. Dong, J. Zhao, H. Wang, Q. Liu, H.J. Lee, W. Jin, Z.-J. Chen, Brown adipose tissue 811 
transplantation ameliorates polycystic ovary syndrome, Proc. Natl. Acad. Sci. 113 (2016) 812 
2708–2713. doi:10.1073/pnas.1523236113. 813 
[108] M. Kikai, H. Yamada, N. Wakana, K. Terada, K. Yamamoto, N. Wada, S. Motoyama, M. 814 
Saburi, T. Sugimoto, D. Irie, T. Kato, H. Kawahito, T. Ogata, S. Matoba, Transplantation 815 
of brown adipose tissue inhibits atherosclerosis in apoE-/- mice: contribution of the 816 
activated FGF-21-adiponectin axis, Cardiovasc. Res. (2017). doi:10.1093/cvr/cvx212. 817 
[109] K.I. Stanford, R.J.W. Middelbeek, K.L. Townsend, D. An, E.B. Nygaard, K.M. Hitchcox, 818 
K.R. Markan, K. Nakano, M.F. Hirshman, Y.-H. Tseng, L.J. Goodyear, Brown adipose 819 
tissue regulates glucose homeostasis and insulin sensitivity., J. Clin. Invest. 123 (2013) 820 


















































































































































Figure legends 833 
Figure 1. Schematic representation of brown adipose tissue (BAT) distribution in rodents 834 
and humans. For many years, BAT was thought to be exclusive to rodents and human neonates, 835 
but in the last decade it was discovered that adult humans have active BAT and that its 836 
distribution is similar to that found in rodents. The classical BAT is located in the suprascapular 837 
region, but it is also found around the neck, axillary, paravertebral and perirenal areas. 838 
 839 
Figure 2. Sources for mesenchymal stem cell (MSC) isolation and differentiation into 840 
white, beige or brown adipocytes. Cells with MSC-like characteristics have been isolated from 841 
the placenta, amniotic fluid, and umbilical cord and from several adult tissues, including muscle, 842 
dermis, blood, bone marrow, gingival tissue and adipose tissue. The most common phenotypical 843 
markers of MSCs include CD29, CD44, CD37, CD90, CD105, CD116 and Stro-1. MSCs have 844 
the capability to self-renew and have multilineage potential to differentiate into many 845 
mesodermal cell types. These include myoblasts, osteoblasts, and adipocytes. Brown adipocytes 846 
and myoblasts arise from myogenic cell lineage progenitors that express myogenic transcription 847 
factor Myf5+. In contrast, white adipocytes arise from Myf5- precursors. The origin of beige 848 
adipocytes is still under scrutiny. Existing theories indicate that they are either derived from the 849 
same precursor as white adipocytes or transdifferentiated from pre-existing white adipocytes.  850 
 851 
Figure 3. Thermogenic adipocytes transplantation as a therapeutic strategy to fight 852 
obesity. Schematic representation of the strategy to transplant thermogenic adipocytes for 853 
therapeutic purposes. 1) The first step would be surgical resection of WAT from an obese 854 
patient. 2) Next, the tissue would be disaggregated using collagenase to obtain a single cell 855 
suspension. 3) Mesenchymal stem cells (MSCs) would be separated from the stromal vascular 856 




































































specific differentiation of these MSCs into thermogenic (beige) adipocytes. 5) Finally, the last 858 
step would consist in the transplant of differentiated adipocytes into the obese patient. These 859 
thermogenic adipocytes would work as metabolically active cells and would increase the 860 



























































Main outcomes Refs 
BEIGE OR BROWN CELL TRANSPLANTATION 
Precursor cells from human 
mediastinal BAT 
Autoimmune-mediated 
type 1 diabetic mice fed with HFD 
Sc injection Reduced glucose levels and body weight. [94] 
Brown adipocyte-derived stem cells 
and MSCs lysate 
HFD-induced obese mice 
Injected 
intraperitoneally 
Reduced body weight. Improved non-alcoholic fatty liver disease, non-alcoholic 
steatohepatitis, glucose intolerance, inflammation, and energy homeostasis. 
[95] 
Brown adipocytes from iPSC-derived 
embryoid bodies (iBAs) and from 
mouse embryonic fibroblasts (dBAs) 
HFD-induced obese mice and in a 
type 2 diabetes mouse model 
Sc  Decreased weight gain. Improved glucose tolerance and insulin sensitivity (dBAs). [96] 
Beige adipocyte-derived progenitors 
of human capillary networks 
Autoimmune-mediated 
type 1 diabetic mice 





Streptozotocin-induced type 1 
diabetes mouse model 
Sc region 
Normalized glucose tolerance, loss of adipose tissue and reduced inflammation. 
Increased adiponectin, leptin and IGF-1 levels and decreased glucagon levels. 
[98] 
12-week old mouse BAT HFD-induced obese mice Visceral cavity 
Improved glucose tolerance, insulin sensitivity, and lower body weight. Increased 
norepinephrine, FGF21, and IL-6 levels. 
[100] 
6-week old mouse BAT 
6-week old HFD-induced obese 
mice 
Adjacent to BAT 
Reduced weight gain, improved insulin sensitivity and glucose homeostasis. 
Increased body temperature, energy metabolism, oxygen consumption, and respiratory 
ratio. 
[102] 
8-week old mouse BAT 
8-week old HFD-induced obese 
mice 
Dorsal sc region 
Loss of body weight and fat, increased energy expenditure, and oxygen consumption. 





type 1 diabetic mice 
Sc region 
Euglycemia. Increased adiponectin and IGF-1 levels and decreased inflammation and 
glucagon levels. 
[99] 
6-week old mouse BAT Ob/Ob mice Dorsal sc region 
Improved insulin resistance and hepatic steatosis. Reduced weight gain, increased 
oxygen consumption, energy expenditure, FA oxidation in scWAT and eWAT, and 
increased adiponectin levels and β3-adrenergic receptor expression. 
[70] 





Visceral cavity Improved glucose homeostasis. Cardioprotection. [106] 
11-week old exercise-trained mouse 
scWAT 
12-week old HFD-induced obese 
mice 
Visceral or sc 
cavity 
Improved glucose homeostasis, increased oxygen consumption rate, and UCP1 levels. 





















































3-week old rat BAT 
Dehydroepiandrosterone (DHEA)-
induced polycystic ovary 
syndrome rat 
Adjacent to BAT 
Improved insulin sensitivity and fertility. 
Activated endogenous BAT and increased adiponectin levels. 
[107] 
8-week old mouse BAT Hph-1 mice fed with HFD 
Visceral fat 
regions 
Improved BAT function. Decreased adiposity, glucose intolerance, and insulin 
resistance. 
[104] 
DJ-1 knockout-induced obese 
resistant mice BAT 
 
HFD-induced obese mice Sc region 
Ameliorated body mass gain. Reversed hepatic steatosis, induced UCP1 expression in 
endogenous BAT, and improved glucose tolerance and insulin sensitivity. 
[105] 
12-week old mouse BAT 12-week old ApoE
-/-
 mice Visceral cavity 
Decreased atherosclerotic lesion area and triglyceride levels. Increased oxygen 
consumption, energy expenditure, and FGF-21, norepinephrine and adiponectin levels. 




Table 1. Models for beige or brown cell transplantation and BAT transplantation and their main outcomes in metabolism 868 
BAT, brown adipose tissue; eWAT, epididymal white adipose tissue; Sc, subcutaneous; scWAT, subcutaneous white adipose tissue 869 
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White preadipocyte Brown preadipocyte 
Beige adipocyte White adipocyte 
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Figure 2 Tcf21 Cd137, Epsti1, Tbx1, Tmem26 Zic 1 
1. Surgical resection 
Resection of white adipose 
tissue from obese patient 
2. Tissue digestion 
Using collagenase, the 
tissue is disaggregated 
to obtain a single cell 
suspension 
3. Isolation and 
expansion of MSCs 
4. Lineage specific 
differentiation of MSCs 
MSCs are differentiated into 
thermogenic adipocytes 
MSCs are separated from 
SVFs and cultured to 
allow proliferation 
5. Transplant of thermogenic 
adipocytes to obese patient 
⇑ Metabolic 
rate 
Figure 3 
